In Figure 2A of their paper, Straussman and colleagues tested the effect offibroblast-conditioned medium on the proliferation of BRAF-mutant melanoma cells grownin the presence of the BRAF inhibitor PLX4720. The gene discussed is BRAF; the disease is melanoma.